Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 44Colorectal Neoplasms 22Breast Neoplasms 22Stomach Neoplasms 21Neoplasms 18Esophageal Squamous Cell Carcinoma 12Neoplasm Metastasis 11Nasopharyngeal Carcinoma 11Lung Neoplasms 11Rectal Neoplasms 9Colonic Neoplasms 8Pancreatic Neoplasms 7Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Osteosarcoma 5Brain Neoplasms 5Small Cell Lung Carcinoma 4Recurrence 4Glioblastoma 4Gastrointestinal Neoplasms 4Precision Cell Immunotherapy 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Diseases 3Digestive System Neoplasms 3Carcinoma, Ovarian Epithelial 3

Interventions

Amifostine 4Cisplatin 3Voriconazole 2Radiotherapy 2Paclitaxel 2Methotrexate 2Drug Therapy 2selinexor 1sargramostim 1pazopanib 1lometrexol 1icotinib 1glucarpidase 1camrelizumab 1bismuth tripotassium dicitrate 1apatinib 1Telbivudine 1Surgical Procedures, Operative 1Pregabalin 1Pharmaceutical Preparations 1Ofloxacin 1Nivolumab 1Metronidazole 1Levofloxacin 1Imatinib Mesylate 1Hyperthermic Intraperitoneal Chemotherapy 1Gefitinib 1Folic Acid 1Etoposide 1Esomeprazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Drug-Related Side Effects and Adverse Reactions × Drug Therapy × Clear all
NCT04635956 2020-11-19

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Peking Union Medical College Hospital

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02549911 2015-09-15

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Zhejiang Cancer Hospital

Phase 2 Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡